🇺🇸 FDA
Pipeline program

Qingying oral liquid and modified Da Huang-Huang Lian Xiexin mouthwash

2024-1774

Phase 2 small_molecule active

Quick answer

Qingying oral liquid and modified Da Huang-Huang Lian Xiexin mouthwash for Radiation-induced Oral Mucositis is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Radiation-induced Oral Mucositis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials